ALT and AST are potentially useful surrogates for alcohol-induced liver disease and nonalcoholic fatty liver disease (NAFLD), defined as hepatic steatosis in the absence of excessive alcohol consumption (Kim et al., 2023). This evidence concerns the gene GPT and liver disorder.